Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study

Abstract

Summary Background Non-communicable diseases (NCDs) have been highlighted as important risk factors for COVID-19 mortality. However, insufficient data exist on the wider context of infectious diseases in people with NCDs. We aimed to investigate the association between NCDs and the risk of death from any infection before the COVID-19 pandemic (up to Dec 31, 2019). Methods For this observational study, we used data from the UK Biobank observational cohort study to explore factors associated with infection death. We excluded participants if data were missing for comorbidities, body-mass index, smoking status, ethnicity, and socioeconomic deprivation, and if they were lost to follow-up or withdrew consent. Deaths were censored up to Dec 31, 2019. We used Poisson regression models including NCDs present at recruitment to the UK Biobank (obesity [defined by use of body-mass index] and self-reported hypertension, chronic heart disease, chronic respiratory disease, diabetes, cancer, chronic liver disease, chronic kidney disease, previous stroke or transient ischaemic attack, other neurological disease, psychiatric disorder, and chronic inflammatory and autoimmune rheumatological disease), age, sex, ethnicity, smoking status, and socioeconomic deprivation. Separate models were constructed with individual NCDs replaced by the total number of prevalent NCDs to define associations with multimorbidity. All analyses were repeated with non-infection-related death as an alternate outcome measure to establish differential associations of infection death and non-infection death. Associations are reported as incidence rate ratios (IRR) accompanied by 95% CIs. Findings After exclusion of 9210 (1·8%) of the 502 505 participants in the UK Biobank cohort, our study sample comprised 493 295 individuals. During 5 273 731 person-years of follow-up (median 10·9 years [IQR 10·1–11·6] per participant), 27 729 deaths occurred, of which 1385 (5%) were related to infection. Advancing age, male sex, smoking, socioeconomic deprivation, and all studied NCDs were independently associated with the rate of both infection death and non-infection death. Compared with White ethnicity, a pooled Black, Asian, and minority ethnicity group was associated with a reduced risk of infection death (IRR 0·64, 95% CI 0·46–0·87) and non-infection death (0·80, 0·75–0·86). Stronger associations with infection death than with non-infection death were observed for advancing age (age 65 years vs 45 years: 7·59, 95% CI 5·92–9·73, for infection death vs 5·21, 4·97–5·48, for non-infection death), current smoking ( vs never smoking: 3·69, 3·19–4·26, vs 2·52, 2·44–2·61), socioeconomic deprivation (most vs least deprived quintile: 2·13, 1·78–2·56, vs 1·38, 1·33–1·43), class 3 obesity ( vs non-obese: 2·2...

Sex differences in incidence and mortality of bloodstream infections. Results from the population-based HUNT study in Norway

“…They found a substantially higher sepsis incidence in low-income countries, and the pattern of sepsis incidence and mortality varied according to location, which is not directly comparable to our study population. We identified higher BSI mortality in men which is in line a population-based study of BSI in critically ill adults (31), and a recent study on infection related death in UKBiobank (32). Conversely, some ICU studies report higher sepsis-related mortality in women.…”

Unequal burden of COVID-19 in Hungary: a geographical and socioeconomic analysis of the second wave of the pandemic

“…4 8 12 14 It is now well documented that people with hypertension, obesity and other metabolic disturbances have increased risk of to severe COVID-19 infections. [50][51][52][53][54] In a 2018 study, it was showed that the prevalence of metabolic syndrome and its components (especially that of abdominal obesity, hypertension and elevated fasting glucose level) has increased significantly in the Hungarian population in the last decade, as has the number of individuals whose hypertension and metabolic disturbances remain untreated. 55 They are also at higher risk of contracting the virus because they are more likely to be in public facing jobs, are less likely to be able to work remotely and find it more difficult to isolate if infected.…”

Low grade systemic inflammation is a risk factor for infection death: an observational cohort study

“…We used clinical consensus prior to our analyses to select a range of morbidities that represent a broad spectrum of common disease groups: hypertension, chronic heart disease (ischaemic heart disease and heart failure), chronic respiratory disease, diabetes, prior cancer, chronic liver disease, chronic kidney disease, prior stroke or transient ischaemic attack (TIA), other neurological disease, psychiatric disease and chronic inflammatory and autoimmune rheumatic disease. (20) The number of these morbidities was calculated for each participant as an index of multimorbidity. Self-reported use of non-steroidal anti-inflammatory or immunosuppressive agents (including disease-modifying anti-rheumatic drugs and oral glucocorticoids) was assessed at study enrolment as described in Appendix Table 2 .…”